Main > ONCOLOGY (**) > Lung>NSCLC>MET>ALK+ *** > Treatment > USA. P. ROS1/ALK Inhibitor Tablets

---

USA. P. ROS1/ALK Inhibitor Tablets's subsections
(*) EU Approval Date: 2019. 05.07.
(*) USA Approval Date: 2018. 11.02.
Company
Generic Name: Lorlatinib
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2022. 04.05.
RTM (CA; JP; USA)
RTM (CA; JP; USA) Web-Site
RTM (EU)

USA. P. ROS1/ALK Inhibitor Tablets's products
This section has no products